Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.520
+0.100 (7.04%)
At close: Jun 26, 2026, 4:00 PM EDT
1.480
-0.040 (-2.63%)
After-hours: Jun 26, 2026, 7:55 PM EDT
Acurx Pharmaceuticals Stock Forecast
ACXP's stock price has decreased by -86.58% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Acurx Pharmaceuticals stock have an average target of 17, with a low estimate of 10 and a high estimate of 31. The average target predicts an increase of 1,018.42% from the current stock price of 1.52.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2026.
Analyst Ratings
The average analyst rating for Acurx Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $10 | Buy | Maintains | $10 | +557.89% | May 13, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $10 | Buy | Reiterates | $10 | +557.89% | May 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $31 | Buy | Reiterates | $31 | +1,939.47% | May 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.97
from -5.32
EPS Next Year
-2.13
from -1.97
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.94 | -1.76 | |
| Avg | -1.97 | -2.13 | |
| Low | -2.00 | -2.50 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.